This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Is HCA (HCA) Up 8.1% Since Last Earnings Report?
by Zacks Equity Research
HCA (HCA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Looking for Value? Why It Might Be Time to Try HCA Healthcare (HCA)
by Zacks Equity Research
HCA Healthcare (HCA) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.
HCA Holdings (HCA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
HCA Holdings (HCA) closed the most recent trading day at $134.81, moving -0.21% from the previous trading session.
Community Health Carries on Hospital Sale for Business Rejig
by Zacks Equity Research
Community Health (CYH) is set to sell hospital units for debt reduction and focusing on profitable business areas.
Are Investors Undervaluing HCA Holdings (HCA) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
HCA Holdings (HCA) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, HCA Holdings (HCA) closed at $140.29, marking a +1.85% move from the previous day.
Community Health Down 16% in a Year: Can it Bounce Back?
by Zacks Equity Research
Community Health (CYH) suffers from high debt and low patient volumes, growth strategies is likely to restore its profitability.
The Zacks Analyst Blog Highlights: Berkshire Hathaway, AbbVie, Booking, HCA and Kimberly-Clark
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Berkshire Hathaway, AbbVie, Booking, HCA and Kimberly-Clark
Top Research Reports for Berkshire Hathaway, AbbVie & Booking Holdings
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (BRK.B), AbbVie (ABBV) and Booking Holdings (BKNG).
HCA Holdings (HCA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, HCA Holdings (HCA) closed at $143.95, marking a +1.64% move from the previous day.
The Zacks Analyst Blog Highlights: HCA Healthcare, Molina Healthcare, Johnson & Johnson, Lockheed Martin and Boeing
by Zacks Equity Research
The Zacks Analyst Blog Highlights: HCA Healthcare, Molina Healthcare, Johnson & Johnson, Lockheed Martin and Boeing
HCA (HCA) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
HCA (HCA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
The Zacks Analyst Blog Highlights: HCA Healthcare, Molina Healthcare, Johnson & Johnson, Facebook and Twitter
by Zacks Equity Research
The Zacks Analyst Blog Highlights: HCA Healthcare, Molina Healthcare, Johnson & Johnson, Facebook and Twitter
5 Top Stocks to Make the Most of a Divided Congress
by Tirthankar Chakraborty
Gridlock in Washington bodes well for healthcare and defense stocks, which calls for investing in such a space for the time being.
Acadia Healthcare (ACHC) Misses on Q3 Earnings, Trims View
by Zacks Equity Research
Acadia Healthcare's (ACHC) Q3 earnings missed estimates and declined year over year on increase in expenses.
Election Day 2018: Here Are the Winners & Losers
by Tirthankar Chakraborty
One of the most awaited midterm elections in American history is upon us. Let's thus look at the sectors most likely to be impacted by the election results.
Has HCA Healthcare (HCA) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (HCA) Outperforming Other Medical Stocks This Year?
HCA Healthcare's (HCA) Q3 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) Q3 earnings improve on the back of rising admissions.
HCA Holdings (HCA) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
HCA (HCA) delivered earnings and revenue surprises of 11.92% and 1.46%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Are Investors Undervaluing HCA Holdings (HCA) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
What's in the Cards for HCA Healthcare (HCA) in Q3 Earnings?
by Zacks Equity Research
HCA Healthcare's (HCA) Q3 results are likely to be aided by strong revenues, driven by higher admissions.
HCA Holdings (HCA) Q3 Earnings Preview: What's in the Cards?
by Zacks Equity Research
HCA (HCA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is HCA Healthcare (HCA) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (HCA) Outperforming Other Medical Stocks This Year?
Why HCA (HCA) Could Beat Earnings Estimates Again
by Zacks Equity Research
HCA (HCA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
MEDNAX Buys Radiology Specialists to Expand Business
by Zacks Equity Research
MEDNAX (MD) boosts its radiology business with the acquisition of Radiology Specialists.